Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06425900 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT06425900 · ClinicalTrials.gov record · last posted 2026-01-21

A Study to Assess Sebaceous Gland Changes and Constituents of Sebum (Skin Oil) Induced by Clascoterone 1% Cream in Acne Patients

StatusActive, Not Recruiting
PhasePhase 4
Started2024-07-01
View on ClinicalTrials.gov ↗
Record status
This record was last updated January 21, 2026 (before its estimated March 2026 completion). Its status may not reflect the trial's current state.
from the ClinicalTrials.gov record
to compare facial sebaceous gland morphology after 3 months of clascoterone cream 1% treatment and to compare facial sebum constituents at baseline to facial sebum constituents after 3 months of clascoterone cream 1% treatment

Amendment record 4 amendments on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended 4 times since 2024-05-21; most recent amendment 2026-01-19. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

2024-10-18
Status change Not Yet Recruiting→Active, Not Recruitingv1
Trial Details
NCT Number NCT06425900
Lead Sponsor Sun Pharmaceutical Industries Limited
Conditions Acne Vulgaris
Enrollment 10 participants
Start Date 2024-07-01
Primary Completion 2026-03 (estimated)
Study Completion 2026-03 (estimated)
Updated on ClinicalTrials.gov 2026-01-21